Parnell Pharmaceuticals (OTCMKTS:PARNF) Upgraded to “Buy” at ValuEngine

ValuEngine upgraded shares of Parnell Pharmaceuticals (OTCMKTS:PARNF) from a hold rating to a buy rating in a report published on Thursday, ValuEngine reports.

Parnell Pharmaceuticals stock opened at $0.20 on Thursday. Parnell Pharmaceuticals has a fifty-two week low of $0.12 and a fifty-two week high of $0.77. The firm’s 50-day simple moving average is $0.28 and its 200 day simple moving average is $0.30.

About Parnell Pharmaceuticals

Parnell Pharmaceuticals Holdings Ltd, a veterinary pharmaceutical company, focuses on developing, manufacturing, and commercializing various animal health solutions. The company operates through four segments: Companion Animal, Production Animal — U.S., Production Animal — Rest of World, and Contract Manufacturing.

Further Reading: Average Daily Trade Volume – What You Need to Know

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Parnell Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Parnell Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.